Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

‘Power to the People’ and mining

The 1960s and 70s were decades of incredible social upheaval. Fed up with wars, governments out of touch with their ideals, authority figures who didn’t get them, the “flower children” of the '60s took to the streets to demand equal ri...
Richard (Rick) Mills | November 4, 2019 |

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |

Cryptocurrency A New Beginning in the Offing

Whenever someone says the word cryptocurrency, the first thing that comes to the mind is Bitcoin. This virtual token of currency became all the more famous when its value rose to $20,000 in December 2017. However, after that Bitcoin saw a huge crash and its value decrease...
Ved Prakash | February 22, 2019 |

Buzz on the Bullboards: A Deeper Look into New Energy Opportunities

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” With a new President in the White House and a new administration, it is like a massive “reset” button is about to be ...
Stockhouse Editorial | January 20, 2021 |

Skechers Puts its Best Foot Forward with Record Quarterly Sales

Skechers USA reported record global sales for the second quarter. International sales led the way in the quarter with an increase of 19.8% over the same period last year. Lifestyle and performance footwear company Skechers USA Inc. (SKX:NYSE) reported ...
Streetwise Reports | July 22, 2019 |

Klondike Golden Moments

Foreword: This tale grew from a chance nugget discovery along the shore of a humble Yukon creek carving through the remote Territory and became the great history of the Klondike Gold Rush. Join author James Kwantes as he touches down in the Yukon with 12 exciting stories and c...
James Kwantes | August 15, 2019 |

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report. In a May 17 report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc. (INO:NASDAQ) will collaborate with QIAGEN, a molecula...
Streetwise Reports | May 27, 2019 |

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...
Streetwise Reports | July 24, 2019 |
1 2 3 4 5 6 7